CIRCULATING TUMOR CELL ENUMERATION PRODUCT

该项目由NCI小企业创新研究（SBIR）和小企业技术转让（STTR）计划资助，作为第一阶段合同，以响应第272号资助公告“循环肿瘤细胞的护理点分析用于癌症诊断，预后和治疗。“循环肿瘤细胞（CTC）是从原发性肿瘤或其转移瘤脱落并在外周血中循环的癌细胞。虽然转移直接导致大多数癌症死亡，但CTC可能构成转移的种子，并有助于疾病的传播。因此CTC相关应用的开发是非常重要的。

This project was funded as a Phase I contract by the NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program in response to funding announcement number 272 "Point of Care Analysis of Circulating Tumor Cells for Cancer Diagnostics, Prognosis, and Treatment."Circulating tumor cells (CTCs) are cancer cells that shed from either the primary tumor or its metastases and are circulating in the peripheral blood. While metastases are directly responsible for the majority of cancer deaths, CTCs may constitute seeds for metastases and are instrumental for the spread of the disease. Therefore the development of CTC-related applications is very important.